A Case Report of Pulmonary Exacerbation after Initiation of Lumacaftor/Ivacaftor Therapy in a CF Female with Complicated Lung Disease

Novel targeted treatments for Cystic Fibrosis give rise to new hope for an ever-growing number of CF patients with various mutations. However, very little evidence and guidelines exist to steer clinical decisions regarding patients whose illness takes an unexpected course. In such cases, the benefit...

Full description

Saved in:
Bibliographic Details
Main Authors: Elpis Hatziagorou, Eleana Kouroukli, Vasiliki Georgopoulou, John Tsanakas
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Case Reports in Pulmonology
Online Access:http://dx.doi.org/10.1155/2018/8394370
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565669157142528
author Elpis Hatziagorou
Eleana Kouroukli
Vasiliki Georgopoulou
John Tsanakas
author_facet Elpis Hatziagorou
Eleana Kouroukli
Vasiliki Georgopoulou
John Tsanakas
author_sort Elpis Hatziagorou
collection DOAJ
description Novel targeted treatments for Cystic Fibrosis give rise to new hope for an ever-growing number of CF patients with various mutations. However, very little evidence and guidelines exist to steer clinical decisions regarding patients whose illness takes an unexpected course. In such cases, the benefits and risks of discontinuing these treatments must be carefully and individually weighed, since their long-term effects remain mainly uncharted territory. In this report we document the case of a homozygous F508del CF patient with severe lung disease who presented with a pulmonary exacerbation shortly after the beginning of treatment with lumacaftor/ivacaftor and the complicated initial phase of therapy, which was followed by significant improvements.
format Article
id doaj-art-b95b97f563ec4b32b56afb2c20b47ad9
institution Kabale University
issn 2090-6846
2090-6854
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Case Reports in Pulmonology
spelling doaj-art-b95b97f563ec4b32b56afb2c20b47ad92025-02-03T01:07:03ZengWileyCase Reports in Pulmonology2090-68462090-68542018-01-01201810.1155/2018/83943708394370A Case Report of Pulmonary Exacerbation after Initiation of Lumacaftor/Ivacaftor Therapy in a CF Female with Complicated Lung DiseaseElpis Hatziagorou0Eleana Kouroukli1Vasiliki Georgopoulou2John Tsanakas33rd Paediatric Department, CF Unit, Hippokration General Hospital of Thessaloniki, Aristotle University of Thessaloniki, Greece3rd Paediatric Department, CF Unit, Hippokration General Hospital of Thessaloniki, Aristotle University of Thessaloniki, GreeceRadiology Department, Hippokration General Hospital of Thessaloniki, Greece3rd Paediatric Department, CF Unit, Hippokration General Hospital of Thessaloniki, Aristotle University of Thessaloniki, GreeceNovel targeted treatments for Cystic Fibrosis give rise to new hope for an ever-growing number of CF patients with various mutations. However, very little evidence and guidelines exist to steer clinical decisions regarding patients whose illness takes an unexpected course. In such cases, the benefits and risks of discontinuing these treatments must be carefully and individually weighed, since their long-term effects remain mainly uncharted territory. In this report we document the case of a homozygous F508del CF patient with severe lung disease who presented with a pulmonary exacerbation shortly after the beginning of treatment with lumacaftor/ivacaftor and the complicated initial phase of therapy, which was followed by significant improvements.http://dx.doi.org/10.1155/2018/8394370
spellingShingle Elpis Hatziagorou
Eleana Kouroukli
Vasiliki Georgopoulou
John Tsanakas
A Case Report of Pulmonary Exacerbation after Initiation of Lumacaftor/Ivacaftor Therapy in a CF Female with Complicated Lung Disease
Case Reports in Pulmonology
title A Case Report of Pulmonary Exacerbation after Initiation of Lumacaftor/Ivacaftor Therapy in a CF Female with Complicated Lung Disease
title_full A Case Report of Pulmonary Exacerbation after Initiation of Lumacaftor/Ivacaftor Therapy in a CF Female with Complicated Lung Disease
title_fullStr A Case Report of Pulmonary Exacerbation after Initiation of Lumacaftor/Ivacaftor Therapy in a CF Female with Complicated Lung Disease
title_full_unstemmed A Case Report of Pulmonary Exacerbation after Initiation of Lumacaftor/Ivacaftor Therapy in a CF Female with Complicated Lung Disease
title_short A Case Report of Pulmonary Exacerbation after Initiation of Lumacaftor/Ivacaftor Therapy in a CF Female with Complicated Lung Disease
title_sort case report of pulmonary exacerbation after initiation of lumacaftor ivacaftor therapy in a cf female with complicated lung disease
url http://dx.doi.org/10.1155/2018/8394370
work_keys_str_mv AT elpishatziagorou acasereportofpulmonaryexacerbationafterinitiationoflumacaftorivacaftortherapyinacffemalewithcomplicatedlungdisease
AT eleanakouroukli acasereportofpulmonaryexacerbationafterinitiationoflumacaftorivacaftortherapyinacffemalewithcomplicatedlungdisease
AT vasilikigeorgopoulou acasereportofpulmonaryexacerbationafterinitiationoflumacaftorivacaftortherapyinacffemalewithcomplicatedlungdisease
AT johntsanakas acasereportofpulmonaryexacerbationafterinitiationoflumacaftorivacaftortherapyinacffemalewithcomplicatedlungdisease
AT elpishatziagorou casereportofpulmonaryexacerbationafterinitiationoflumacaftorivacaftortherapyinacffemalewithcomplicatedlungdisease
AT eleanakouroukli casereportofpulmonaryexacerbationafterinitiationoflumacaftorivacaftortherapyinacffemalewithcomplicatedlungdisease
AT vasilikigeorgopoulou casereportofpulmonaryexacerbationafterinitiationoflumacaftorivacaftortherapyinacffemalewithcomplicatedlungdisease
AT johntsanakas casereportofpulmonaryexacerbationafterinitiationoflumacaftorivacaftortherapyinacffemalewithcomplicatedlungdisease